These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

87 related articles for article (PubMed ID: 1337723)

  • 21. Analysis of transforming growth factor (TGF)-alpha/epidermal growth factor receptor, hepatocyte growth Factor/c-met,TGF-beta receptor type II, and p53 expression in human hepatocellular carcinomas.
    Kiss A; Wang NJ; Xie JP; Thorgeirsson SS
    Clin Cancer Res; 1997 Jul; 3(7):1059-66. PubMed ID: 9815784
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Abnormal nucleotide repeat sequence in the TGF-betaRII gene in hepatocellular carcinoma and in uninvolved liver tissue.
    Enomoto A; Esumi M; Yamashita K; Takagi K; Takano S; Iwai S
    J Pathol; 2001 Oct; 195(3):349-54. PubMed ID: 11673833
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Expression of insulin-like growth factor II in chronic hepatitis B, liver cirrhosis, and hepatocellular carcinoma.
    Seo JH; Park BC
    Gan To Kagaku Ryoho; 1995 Aug; 22 Suppl 3():292-307. PubMed ID: 7661600
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Changes in the antioxidant defense and hepatic drug metabolizing enzyme and isoenzyme levels, 8-hydroxydeoxyguanosine formation and expressions of c-raf.1 and insulin-like growth factor II genes during the stages of development of hepatocellular carcinoma in rats.
    Mukherjee B; Das T; Ghosh S; Datta S
    Eur J Cancer Prev; 2007 Aug; 16(4):363-71. PubMed ID: 17554210
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Transcripts of the insulin-like growth factors I and II in human hepatoma.
    Su TS; Liu WY; Han SH; Jansen M; Yang-Fen TL; P'eng FK; Chou CK
    Cancer Res; 1989 Apr; 49(7):1773-7. PubMed ID: 2466561
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The insulin-like growth factor axis and prostate cancer: lessons from the transgenic adenocarcinoma of mouse prostate (TRAMP) model.
    Kaplan PJ; Mohan S; Cohen P; Foster BA; Greenberg NM
    Cancer Res; 1999 May; 59(9):2203-9. PubMed ID: 10232609
    [TBL] [Abstract][Full Text] [Related]  

  • 27. A possible role for insulin-like growth factor-binding protein-3 autocrine/paracrine loops in controlling hepatocellular carcinoma cell proliferation.
    Huynh H; Chow PK; Ooi LL; Soo KC
    Cell Growth Differ; 2002 Mar; 13(3):115-22. PubMed ID: 11959812
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Increased expression of the insulin-like growth factor I (IGF-I) receptor gene in hepatocellular carcinoma cell lines: implications of IGF-I receptor gene activation by hepatitis B virus X gene product.
    Kim SO; Park JG; Lee YI
    Cancer Res; 1996 Aug; 56(16):3831-6. PubMed ID: 8706031
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Study on the expression and genomic imprinting status of insulin-like growth factor 2 gene in hepatocellular carcinoma].
    Li H; Zhang N
    Zhonghua Gan Zang Bing Za Zhi; 2004 Jun; 12(6):347-9. PubMed ID: 15225429
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Expression of mRNA for the insulin-like growth factors and their receptors in human preimplantation embryos.
    Lighten AD; Hardy K; Winston RM; Moore GE
    Mol Reprod Dev; 1997 Jun; 47(2):134-9. PubMed ID: 9136113
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The role of the IGF axis in hepatocarcinogenesis.
    Scharf JG; Braulke T
    Horm Metab Res; 2003; 35(11-12):685-93. PubMed ID: 14710347
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The relationship of insulin-like growth factor-II, insulin-like growth factor binding protein-3, and estrogen receptor-alpha expression to disease progression in epithelial ovarian cancer.
    Lu L; Katsaros D; Wiley A; Rigault de la Longrais IA; Risch HA; Puopolo M; Yu H
    Clin Cancer Res; 2006 Feb; 12(4):1208-14. PubMed ID: 16489075
    [TBL] [Abstract][Full Text] [Related]  

  • 33. An evaluation of the role of insulin-like growth factors (IGF) and of type-I IGF receptor signalling in hepatocarcinogenesis and in the resistance of hepatocarcinoma cells against drug-induced apoptosis.
    Alexia C; Fallot G; Lasfer M; Schweizer-Groyer G; Groyer A
    Biochem Pharmacol; 2004 Sep; 68(6):1003-15. PubMed ID: 15313394
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Insulin-like growth factor II induced by hypoxia may contribute to angiogenesis of human hepatocellular carcinoma.
    Kim KW; Bae SK; Lee OH; Bae MH; Lee MJ; Park BC
    Cancer Res; 1998 Jan; 58(2):348-51. PubMed ID: 9443416
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Altered transcriptional regulation of the insulin-like growth factor 2 gene in human hepatocellular carcinoma.
    Uchida K; Kondo M; Takeda S; Osada H; Takahashi T; Nakao A; Takahashi T
    Mol Carcinog; 1997 Apr; 18(4):193-8. PubMed ID: 9142213
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Inhibition mechanism of a newly cloned candidate tumor suppressor gene JST during hepatocarcinogenesis and its abnormal expression in human hepatocellular carcinoma from Qidong liver cancer risk area, China.
    Dong-Dong L; Xi-Ran Z
    Hepatogastroenterology; 2004; 51(56):515-25. PubMed ID: 15086194
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Impact of insulin-like growth factor 2, insulin-like growth factor receptor 2, insulin receptor substrate 2 genes polymorphisms on susceptibility and clinicopathological features of hepatocellular carcinoma.
    Rashad NM; El-Shal AS; Abd Elbary EH; Abo Warda MH; Hegazy O
    Cytokine; 2014 Jul; 68(1):50-8. PubMed ID: 24656929
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Insulin-like growth factor I receptor β expression in hepatocellular carcinoma.
    Liu X; Jiang W; Aucejo F; Kim R; Miller C; Byrne M; Lopez R; Yerian L
    Hum Pathol; 2011 Jun; 42(6):882-91. PubMed ID: 21292299
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The human hepatitis B virus transactivator X gene product regulates Sp1 mediated transcription of an insulin-like growth factor II promoter 4.
    Lee YI; Lee S; Lee Y; Bong YS; Hyun SW; Yoo YD; Kim SJ; Kim YW; Poo HR
    Oncogene; 1998 May; 16(18):2367-80. PubMed ID: 9620554
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Expression of insulin-like growth factor II and receptors for insulin-like growth factor II, insulin-like growth factor I and insulin in isolated and cultured rat hepatocytes.
    Lamas E; Zindy F; Seurin D; Guguen-Guillouzo C; Brechot C
    Hepatology; 1991 May; 13(5):936-40. PubMed ID: 1851495
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.